Cargando…
Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma
Chemotherapy is among the limited choices approved for the treatment of hepatocellular carcinoma (HCC) at intermediate and advanced stages. Preferential and prolonged drug exposure in diseased sites is required to maximize the therapeutic index of the drug. Here, we report an injectable supramolecul...
Autores principales: | Zhao, Xiyue, Liu, Xiaoyu, Zhang, Pengcheng, Liu, Yiran, Ran, Wei, Cai, Ying, Wang, Junyang, Zhai, Yihui, Wang, Guanru, Ding, Yaping, Li, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804453/ https://www.ncbi.nlm.nih.gov/pubmed/31649853 http://dx.doi.org/10.1016/j.apsb.2019.06.001 |
Ejemplares similares
-
In Vivo Imaging of Click-Crosslinked Hydrogel Depots Following Intratympanic Injection
por: Ju, Hyeon Jin, et al.
Publicado: (2020) -
Dynamic Covalent
Dextran Hydrogels as Injectable,
Self-Adjuvating Peptide Vaccine Depots
por: Fan, Bowen, et al.
Publicado: (2023) -
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles
por: Ottonelli, Ilaria, et al.
Publicado: (2022) -
Acupoint nanocomposite hydrogel for simulation of acupuncture and targeted delivery of triptolide against rheumatoid arthritis
por: Ren, Shujing, et al.
Publicado: (2021) -
Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion
por: Chen, Chih-Hao, et al.
Publicado: (2018)